1984
DOI: 10.1016/0092-8674(84)90382-9
|View full text |Cite
|
Sign up to set email alerts
|

Transcriptional activation of the translocated c-myc oncogene in mouse plasmacytomas: Similar RNA levels in tumor and proliferating normal cells

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

5
63
2
1

Year Published

1984
1984
2006
2006

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 118 publications
(71 citation statements)
references
References 28 publications
5
63
2
1
Order By: Relevance
“…On a per cell basis, however, the total atnount of c-myc RNA in leukemic blast cells actually has increased more than indicated by the specific measurement of c-myc RNA relative to total mRNA because flow cytometric measurements of RNA with acridine orange staining have shown that the mean RNA content of leukemia cells is approxi- mately twofold higher than that in normal thymocytes (14). Similar results were reported in mouse plasmacytomas in which relative c-myc RNA levels were only four times higher than those in quiescent B cells (7). In this latter work it was estimated that tumor cells contained eight times more RNA resulting in a 30-fold-higher level of c-myc RNA per cell compared with controls.…”
supporting
confidence: 75%
“…On a per cell basis, however, the total atnount of c-myc RNA in leukemic blast cells actually has increased more than indicated by the specific measurement of c-myc RNA relative to total mRNA because flow cytometric measurements of RNA with acridine orange staining have shown that the mean RNA content of leukemia cells is approxi- mately twofold higher than that in normal thymocytes (14). Similar results were reported in mouse plasmacytomas in which relative c-myc RNA levels were only four times higher than those in quiescent B cells (7). In this latter work it was estimated that tumor cells contained eight times more RNA resulting in a 30-fold-higher level of c-myc RNA per cell compared with controls.…”
supporting
confidence: 75%
“…The transcription factor c-Myc is a well known oncogene (23,24), which enhances cell proliferation by regulating cell-cycle regulators, including cyclin D1 and E2F1 (15,16). Our data provide evidence that R1 interacts and colocalizes with c-Myc in SK-N-BE(2)-C cells.…”
Section: R1 and C-myc Enhance Proliferation Via Similar Mechanismssupporting
confidence: 51%
“…All of these plasmacytomas, except J606, have c-myc genes translocated to the Ca locus, although some of these tumors express isotypes other than alpha. M104E (immunoglobulin M) is unusual in that it has a c-myc gene translocated just 3' of the Ca gene (24). In all cases, the translocated c-myc gene was significantly more sensitive to DNase I than the normal c-myc gene.…”
mentioning
confidence: 99%
“…This demonstrates a requirement for B-cell-specific factors and suggests that B-cell factors normally involved in immunoglobulin gene transcription may also activate the cryptic c-myc promoters translocated adjacent to immunoglobulin genes. With few exceptions (7,11,16,22,39), the known immunoglobulin heavy-chain enhancer (3,19,29,30) does not remain on the same chromosome as the translocated c-myc gene and thus is not responsible for this activation (18,24,29,35). Since DNase I-sensitive structure is associated with active genes (23,44 46), we reasoned that an analysis of c-myc gene chromatin in plasmacytomas might provide insight into mechanisms responsible for activation of the cryptic promoters.…”
mentioning
confidence: 99%
See 1 more Smart Citation